Why use Phage Display over Hybridoma for Bovine Antibody Discovery?

Hybridoma technology relies on the fusion of B-cells with myeloma cells. Efficient bovine myeloma partners are scarce and unstable, leading to low fusion rates and loss of valuable clones. Phage display-based Bovine (Cattle) Monoclonal Antibody discovery bypasses fusion entirely, allowing us to immortalize the entire antibody repertoire in a DNA library, ensuring no rare high-affinity clone is left behind.

Can you specifically target the "Ultralong CDR3" antibodies?

Yes. Our construction and screening of immune antibody library process utilizes specific primer sets that recognize the unique framework regions associated with ultralong CDR3s. We can enrich the library for these unique structural variants if your research requires targeting cryptic epitopes.

What is the typical size of the immune antibody library for Bovine (Cattle) Monoclonal Antibody?

We guarantee a library size of at least 1×10^8 independent transformants, though our libraries frequently reach 10^9 to 10^10 CFU. This high diversity is crucial for isolating rare binders with sub-nanomolar affinity.

Do you provide the antibody sequence?

Absolutely. Upon completion of the project, you receive the full DNA and amino acid sequences of the identified clones, along with the physical plasmid DNA and purified antibody samples.

Can this service be used for targets other than proteins?

Yes. We have successfully generated Bovine (Cattle) Monoclonal Antibodies against peptides, small molecules (haptens), and whole cells. The immunization strategy is adjusted to ensure proper presentation of non-protein antigens.

Advanced Bovine (Cattle) Monoclonal Antibody Discovery Service

Background Platform Workflow Advantage Related Services FAQ Online Inquiry

At Creative Biolabs, we stand at the forefront of antibody engineering, leveraging over two decades of expertise to unlock the unique potential of host-specific immune systems. We are proud to offer our industry-leading Bovine (Cattle) Monoclonal Antibody Discovery Service, a specialized platform designed to exploit the exceptional structural characteristics of bovine antibodies—specifically their ultralong CDR3 regions—for research, diagnostic, and veterinary therapeutic development.

Discuss Your Project Today

The Unique Advantage of Bovine Antibodies: Accessing the Inaccessible

In the realm of antibody discovery, the bovine immune system is an evolutionary marvel. Unlike rodents or humans, cattle produce a subset of antibodies with exceptionally long Complementarity Determining Region 3 (CDR3) loops in their heavy chains. These ultralong CDR3s, often exceeding 60 amino acids, form a unique "knob and stalk" architecture.

This structural anomaly allows Bovine (Cattle) Monoclonal Antibodies to penetrate cryptic epitopes—deep pockets, recessed canyons on viral surfaces, and active sites of enzymes—that are typically inaccessible to standard human or murine antibodies.

Table 1. Comparison of Antibody Architectures

Feature	Murine (Mouse) IgG	Human IgG	Bovine (Cattle) IgG (Ultralong)
CDR3 Length	~9-12 amino acids	~12-16 amino acids	Up to 60+ amino acids
Structural Motif	Canonical loop	Canonical loop	Stalk and Knob domain
Diversity Mechanism	V(D)J Recombination	V(D)J Recombination	Somatic Hypermutation & Cysteine Disulfides
Epitope Access	Flat/Planar surfaces	Flat/Planar surfaces	Recessed/Cryptic pockets
Therapeutic Potential	High (after humanization)	High	High (Veterinary & Unique Human Scaffolds)

At Creative Biolabs, we utilize this unique biology to assist clients in developing reagents against difficult targets such as G-protein-coupled receptors (GPCRs) and ion channels.

Fig. 1 Bovine Fv crystal structures and sequence alignment of the CDRH3 regions.¹

Our Technology: Bovine (Cattle) Monoclonal Antibody Discovery by Phage Display

While hybridoma technology has been the gold standard for decades, it faces significant hurdles in bovine species due to the lack of stable myeloma fusion partners and low fusion efficiency. Creative Biolabs has overcome these limitations by establishing a robust Bovine (Cattle) Monoclonal Antibody Discovery by phage display immune antibody library platform.

Our approach bypasses the inefficiencies of cell fusion, allowing for the direct capture of the entire heavy and light chain repertoire from immunized cattle. By utilizing phage display, we can screen billions of candidates to isolate high-affinity binders with picomolar sensitivity.

The Core Process: Construction and Screening of Immune Antibody Library

The success of our service hinges on the quality of the library. We do not simply clone genes; we capture the immunological history of the host. Our workflow for the construction and screening of immune antibody library involves:

Hyper-Immunization: We employ proprietary adjuvants and immunization schedules to elicit a potent humoral response in the host cattle against your target antigen.
PBMC Isolation: Peripheral Blood Mononuclear Cells (PBMCs) are harvested during the peak immune response window.
RNA Extraction & cDNA Synthesis: High-fidelity reverse transcription preserves the diversity of the variable regions.
V-Region Amplification: We use optimized degenerate primers specifically designed for bovine VH and VL regions, ensuring the capture of ultralong CDR3 variants.
Phage Library Assembly: The scFv or Fab fragments are cloned into our phagemid vectors, creating a high-diversity immune antibody library for Bovine (Cattle) Monoclonal Antibody.

Detailed Service Workflow of Bovine (Cattle) Monoclonal Antibody Discovery

We offer a modular, end-to-end solution. Below is the trajectory of a typical Bovine (Cattle) Monoclonal Antibody Discovery project.

Phase 1: Antigen Preparation and Animal Immunization

Success starts with the antigen. We accept client-supplied antigens or generate them in-house (proteins, peptides, DNA, or whole cells).

Phase 2: Construction of Phage Display Immune Antibody Library

This is where Creative Biolabs excels. We construct a phage display-based Bovine (Cattle) Monoclonal Antibody library with a diversity size typically exceeding 1×10^9 CFU.

Format: Single-chain variable fragment (scFv) or Antigen-binding fragment (Fab).
Optimization: Introduction of specific cysteine residues to stabilize the ultralong CDR3 "knob" domain during display.

Phase 3: Biopanning and Screening

We employ solid-phase, solution-phase, or cell-based panning strategies to select specific binders.

Rounds: Typically 3–4 rounds of panning with increasing stringency.
High-Throughput Screening: ELISA or FACS analysis of individual clones.
Sequencing: Identification of unique gene sequences to validate the Bovine (Cattle) Monoclonal Antibody candidates.

Phase 4: Expression and Characterization

Top candidates are expressed in mammalian systems (CHO or HEK293 cells) and characterized for:

Affinity: Measured via Surface Plasmon Resonance (SPR / Biacore) or Octet.
Specificity: Cross-reactivity analysis.
Epitope Binning: Determining binding sites.

Why Choose Creative Biolabs for Bovine Antibody Discovery?

The generation of immune antibody library for Bovine (Cattle) Monoclonal Antibody requires more than standard molecular biology skills; it requires a deep understanding of bovine immunology.

Unrivaled Library Diversity: Our primer sets are iteratively optimized to ensure the ultralong CDR3 repertoire is not lost during PCR amplification—a common failure point in competitor protocols.
High Affinity Guarantee: By utilizing an immune antibody library, we harvest antibodies that have already undergone in vivo affinity maturation, resulting in tighter binders compared to naïve libraries.
Tailored Strategies: We adapt our screening strategy (blocking, depletion, competitive elution) based on the nature of your antigen.
Versatile Platforms: We offer M13 phage display, but can also utilize yeast display for specific complex targets.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Our Bovine (Cattle) Monoclonal Antibody Discovery platform is ready to tackle your most challenging targets, providing you with unique tools that standard murine antibodies cannot match. Let us help you accelerate your research with the power of the bovine immune system.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: Why use Phage Display over Hybridoma for Bovine Antibody Discovery?
A: Hybridoma technology relies on the fusion of B-cells with myeloma cells. Efficient bovine myeloma partners are scarce and unstable, leading to low fusion rates and loss of valuable clones. Phage display-based Bovine (Cattle) Monoclonal Antibody discovery bypasses fusion entirely, allowing us to immortalize the entire antibody repertoire in a DNA library, ensuring no rare high-affinity clone is left behind.
Q: Can you specifically target the "Ultralong CDR3" antibodies?
A: Yes. Our construction and screening of immune antibody library process utilizes specific primer sets that recognize the unique framework regions associated with ultralong CDR3s. We can enrich the library for these unique structural variants if your research requires targeting cryptic epitopes.
Q: What is the typical size of the immune antibody library for Bovine (Cattle) Monoclonal Antibody?
A: We guarantee a library size of at least 1×10⁸ independent transformants, though our libraries frequently reach 10⁹ to 10¹⁰ CFU. This high diversity is crucial for isolating rare binders with sub-nanomolar affinity.
Q: Do you provide the antibody sequence?
A: Absolutely. Upon completion of the project, you receive the full DNA and amino acid sequences of the identified clones, along with the physical plasmid DNA and purified antibody samples.
Q: Can this service be used for targets other than proteins?
A: Yes. We have successfully generated Bovine (Cattle) Monoclonal Antibodies against peptides, small molecules (haptens), and whole cells. The immunization strategy is adjusted to ensure proper presentation of non-protein antigens.

Reference

Dong, Jinhui, et al. "Structural diversity of ultralong CDRH3s in seven bovine antibody heavy chains." Frontiers in immunology 10 (2019): 558. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2019.00558

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.